| Name | Tetrahydrozoline hydrochloride |
| Description | Tetrahydrozoline hydrochloride (Murine Plus) is an imidazoline derivative with alpha receptor agonist activity. |
| In vitro | Tetrahydrozoline HCl is an imidazoline derivative with alpha receptor agonist activity. [1] Its main mechanism of action is the constriction of conjunctival blood vessels. [2] |
| In vivo | Tetrahydrozoline HCl inhibits settlement of the Barnacle Balanus improvisus at 1 μM. [2] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (4.22 mM), Sonication is recommended. H2O : 43 mg/mL (181.63 mM), Sonication is recommended. Ethanol : 25 mg/mL (105.6 mM), Sonication is recommended. DMSO : 10 mg/mL (42.24 mM), Sonication is recommended.
|
| Keywords | α-adrenergic receptor | Tetryzoline Hydrochloride | Tetryzoline | Tetrahydrozoline hydrochloride | Tetrahydrozoline Hydrochloride | Tetrahydrozoline | ophthalmic | nasal | Inhibitor | inhibit | conjunctival | congestion | Beta Receptor | AdrenergicReceptor | Adrenergic Receptor |
| Inhibitors Related | Olanzapine | Mirtazapine | Octopamine hydrochloride | Gemfibrozil | Buflomedil hydrochloride | Dexmedetomidine hydrochloride | Phenylephrine hydrochloride | Amitriptyline hydrochloride | Isoprenaline hydrochloride | Trazodone hydrochloride | Mianserin hydrochloride | Doxepin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Adrenergic Receptor-Targeted Compound Library | GPCR Compound Library | Anti-Cancer Drug Library |